Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




IFCC Celebrates 70 Years of Advancing Science of Laboratory Medicine and In Vitro Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2022

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC, Milano, Italy) is celebrating 70 years (1952 – 2022) of enormous achievements that have been extraordinary and impressive. Many important milestones have been accomplished contributing to the IFCC’s mission of “Advancing excellence in laboratory medicine for better healthcare worldwide”.

Particularly remarkable are the many golden achievements by the Scientific Division, Education and Management Division, Communications and Publications Division, and the Emerging Technology Division. Clearly, these achievements have not only contributed to the growth of the IFCC organization but have also had important impact on advancing the science of laboratory medicine and in vitro diagnostics around the world.

“I strongly believe that the future holds considerable promise for the IFCC organization and its family of national societies and corporate members,” said Professor Khosrow Adeli, IFCC President. “The strong foundation built by thousands of IFCC officers over the past two decades as highlighted in this report will ensure the IFCC’s continued journey towards global leadership in laboratory medicine, contributing to its most valuable mission of improving clinical decision making and better healthcare worldwide.”

“Many new initiatives are planned over the coming years to further enhance IFCC’s leadership position and increase IFCC’s role in improving global healthcare and improved patient outcomes,” added Professor Khosrow Adeli. “There will be major expansions of the IFCC’s role in global lab quality to improve internal and external quality assurance and in distance learning resources to enhance continuing education for clinical laboratory professionals worldwide. I have no doubt that IFCC will continue to shine and excel, thanks to the contributions of thousands of dedicated scientists who have actively participated and will continue to participate in numerous functional units within the IFCC organization.”

Related Links:
IFCC 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Vaginitis Test
Allplex Vaginitis Screening Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.